H-FSSE-OH

Ref. 3D-PP49922

Informations sur le produit

• Nom: H-FSSE-OH

Description

Peptide H-FSSE-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-FSSE-OH include the following: RAGE and TLRs as key targets for antiatherosclerotic therapy W Olejarz, D à acheta, A Gà ‚uszko - BioMed Research , 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2018/7675286 Extracellular HMGB1 as a therapeutic target in inflammatory diseases U Andersson, H Yang , H Harris - Expert opinion on therapeutic , 2018 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/14728222.2018.1439924 HMGB1 is a promising therapeutic target for acute liver failure T Yamamoto, Y Tajima - Expert Review of Gastroenterology & , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/17474124.2017.1345625 Folic acid derived-P5779 mimetics regulate DAMP-mediated inflammation through disruption of HMGB1: TLR4: MD-2 axes S Sun , M He , Y Wang, H Yang, Y Al-Abed - PloS one, 2018 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0193028 HMGB1: regulation of inflammatory functions and therapeutic blockade P Lundback - 2015 - openarchive.ki.sehttps://openarchive.ki.se/xmlui/handle/10616/44564 Characterization of the ATP-dependent binding of wheat germ protein synthesis initiation factors eIF-(iso) 4F and eIF-4A to mRNA. ML Balasta, SE Carberry, DE Friedland - Journal of Biological , 1993 - ASBMBhttps://www.jbc.org/article/S0021-9258(17)46670-1/abstract Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development M Ross - Kidney International, 2015 - kidney-international.orghttps://www.kidney-international.org/article/S0085-2538(15)30152-6/abstract The Inflammation Superhighway: Tolls, Signals, and Pathways to Bronchopulmonary Dysplasia J Ibrahim, S Garantziotis , RC Savani - Updates on neonatal chronic lung , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/B9780323683531000099 HMGB1-driven inflammation and intimal hyperplasia after arterial injury involves cell-specific actions mediated by TLR4 J Cai , H Yuan, Q Wang, H Yang , Y Al-Abed - , and vascular biology, 2015 - Am Heart Assochttps://www.ahajournals.org/doi/abs/10.1161/ATVBAHA.115.305789 HMGB1 protein: a therapeutic target inside and outside the cell I Ugrinova , E Pasheva - Advances in protein chemistry and structural , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1876162316300542 The HMGB1-MD-2 axis as a novel therapeutic target in inflammatory diseases (CCR5P. 210) H Yang, H Wang, S Chavan , T Billiar - The Journal of , 2015 - journals.aai.orghttps://journals.aai.org/jimmunol/article/194/1_Supplement/186.12/55377 MD-2 is required for disulfide HMGB1-dependent TLR4 signaling H Yang , H Wang , Z Ju, AA Ragab - Journal of Experimental , 2015 - rupress.orghttps://rupress.org/jem/article-abstract/212/1/5/41647 Targeting inflammation driven by HMGB1 H Yang , H Wang , U Andersson - Frontiers in immunology, 2020 - frontiersin.orghttps://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.00484/full High mobility group box protein 1 (HMGB1): the prototypical endogenous danger molecule H Yang , H Wang , SS Chavan , U Andersson - Molecular medicine, 2015 - Springerhttps://link.springer.com/article/10.2119/molmed.2015.00087 HMGB1 as biomarker and drug target E Venereau, F De Leo , R Mezzapelle - Pharmacological , 2016 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S104366181630487X Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury C Deng, L Zhao, Z Yang, J Shang, C Wang - Acta Pharmacologica , 2022 - nature.comhttps://www.nature.com/articles/s41401-021-00676-7 Following the White Rabbit: Release and Regulation of HMGB1 in Inflammation A Sowinska - 2019 - search.proquest.comhttps://search.proquest.com/openview/7c19815c7ce455a2fabdf4b1b422117e/1?pq-origsite=gscholar&cbl=2026366&diss=y Thiocarbazate building blocks enable the construction of azapeptides for rapid development of therapeutic candidates A Altiti, M He , S VanPatten, KF Cheng, U Ahmed - Nature , 2022 - nature.comhttps://www.nature.com/articles/s41467-022-34712-9

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 468.46 g/mol